当前位置:首页 - 行情中心 - 仙琚制药(002332) - 财务分析

仙琚制药

(002332)

  

流通市值:125.53亿  总市值:126.12亿
流通股本:9.85亿   总股本:9.89亿

仙琚制药(002332)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.43亿元,每股收益0.54元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益606858.44万元,未分配利润278119.32万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产690774.02万元,负债83915.58万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入3,237,007,358.822,137,847,609.831,037,926,735.624,123,418,584.19
营业总成本2,606,344,910.381,730,317,120.59872,354,424.53,489,877,858.41
营业利润630,727,222.82409,358,429.14183,979,069.51646,459,105.49
利润总额627,710,393.41407,123,195.07182,129,349.35641,680,548.19
净利润542,697,542.2347,675,890.75156,516,313.26562,118,485.63
其他综合收益-5,397,470.36-32,585,815.58-30,172,868.9544,869,634.17
综合收益总额537,300,071.84315,090,075.17126,343,444.31606,988,119.8
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计3,198,646,646.363,258,905,279.533,521,007,668.763,399,871,398.68
非流动资产合计3,709,093,514.443,686,869,630.393,665,660,896.183,592,963,653.82
资产总计6,907,740,160.86,945,774,909.927,186,668,564.946,992,835,052.5
流动负债合计737,706,582.47993,233,748.921,120,244,305.771,046,909,543.49
非流动负债合计101,449,192.86106,166,772.2110,035,041.43115,879,735.58
负债合计839,155,775.331,099,400,521.121,230,279,347.21,162,789,279.07
归属于母公司股东权益合计6,014,143,118.385,796,496,392.485,907,070,224.25,786,121,230.23
股东权益合计6,068,584,385.475,846,374,388.85,956,389,217.745,830,045,773.43
负债和股东权益合计6,907,740,160.86,945,774,909.927,186,668,564.946,992,835,052.5
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,676,018,442.731,670,566,985.22825,567,894.713,767,192,918.88
经营活动现金流出小计2,458,592,364.891,575,257,880.88716,542,893.153,171,710,560.2
经营活动产生的现金流量净额217,426,077.8495,309,104.34109,025,001.56595,482,358.68
投资活动现金流入小计67,777,522.7665,395,547.1516,111,727.0554,341,332.57
投资活动现金流出小计209,752,623.38140,404,751.5579,871,581.52250,966,728.65
投资活动产生的现金流量净额-141,975,100.62-75,009,204.4-63,759,854.47-196,625,396.08
筹资活动现金流入小计5,000,0001,000,000500,0001,377,776
筹资活动现金流出小计420,007,804.2342,196,516.2515,699,172.59465,225,230.83
筹资活动产生的现金流量净额-415,007,804.2-341,196,516.25-15,199,172.59-463,847,454.83
汇率变动对现金及现金等价物的影响-965,194.56-11,505,302.31-15,771,215.91-13,438,530.56
现金及现金等价物净增加额-340,522,021.54-332,401,918.6214,294,758.59-78,429,022.79
期末现金及现金等价物余额1,289,328,938.681,297,449,041.61,644,145,718.811,629,850,960.22
最新报告期:2024-10-28
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华西证券崔文亮0.700.851.032024-10-28
华创证券郑辰,王宏雨0.690.861.072024-10-28
招商证券许菲菲0.710.861.062024-10-28
浙商证券孙建,郭双喜0.690.851.042024-10-28
中泰证券祝嘉琦0.690.831.022024-10-27
TOP↑